Zydus secures U.S. FDA nod for scurvy injection generic

Zydus secures U.S. FDA nod for scurvy injection generic

The product will be manufactured at the group’s injectable manufacturing plant in Jarod, near Vadodara and marketed in the US by Zydus Pharmaceuticals (USA) Inc

Zydus scores major USFDA win for Ascorbic Acid injection - The Canadian Media

IBNS-CMEDIA: Zydus Lifesciences Limited (Zydus) announces the receipt of final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ascorbic Acid Injection USP, 25,000 mg/50 mL (500 mg/mL) and 5,000 mg/10 mL (500 mg/mL). The product is primarily used for the short-term treatment of scurvy in

Zydus gets final US FDA approval for Ascorbic Acid Injection with 180-Days CGT exclusivity

Zydus Lifesciences announces the receipt of final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ascorbic Acid Injection USP, 25,000 mg/50 mL (500 mg/mL) and 5,000 mg/10 mL (500 mg/mL). The product is primarily used for the short-term treatment of scurvy in adult and paediatric patients aged 5 months and older for whom oral administration is not possible, insufficient or c…